Stephen Baxter
Stock Analyst at Wells Fargo
(3.11)
# 1,018
Out of 4,826 analysts
167
Total ratings
41.75%
Success rate
0.61%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MCK McKesson | Maintains: Equal-Weight | $641 → $691 | $707.00 | -2.26% | 5 | Mar 14, 2025 | |
COR Cencora | Maintains: Equal-Weight | $251 → $274 | $291.97 | -6.15% | 2 | Mar 14, 2025 | |
OSCR Oscar Health | Downgrades: Equal-Weight | $20 → $16 | $12.94 | +23.65% | 10 | Mar 13, 2025 | |
UHS Universal Health Services | Maintains: Overweight | $230 → $225 | $178.19 | +26.27% | 13 | Mar 10, 2025 | |
CYH Community Health Systems | Maintains: Underweight | $2.5 → $2 | $2.84 | -29.58% | 8 | Mar 10, 2025 | |
MOH Molina Healthcare | Upgrades: Overweight | $295 → $372 | $319.63 | +16.38% | 17 | Mar 5, 2025 | |
CNC Centene | Maintains: Overweight | $76 → $72 | $59.78 | +20.44% | 21 | Feb 14, 2025 | |
CVS CVS Health | Maintains: Overweight | $68 → $73 | $67.40 | +8.31% | 13 | Feb 13, 2025 | |
CI The Cigna Group | Maintains: Equal-Weight | $370 → $341 | $333.01 | +2.40% | 6 | Feb 4, 2025 | |
CAH Cardinal Health | Maintains: Equal-Weight | $135 → $136 | $151.99 | -10.52% | 6 | Feb 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $694 → $660 | $404.81 | +63.04% | 10 | Jan 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $483 → $478 | $416.30 | +14.82% | 9 | Jan 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $21 | $20.41 | +2.89% | 3 | Nov 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $205 → $150 | $149.03 | +0.65% | 12 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $400 → $320 | $349.38 | -8.41% | 13 | Nov 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $256.69 | +12.98% | 10 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.06 | +112.46% | 3 | Apr 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $8 | $4.16 | +92.31% | 6 | Feb 26, 2024 |
McKesson
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $641 → $691
Current: $707.00
Upside: -2.26%
Cencora
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $251 → $274
Current: $291.97
Upside: -6.15%
Oscar Health
Mar 13, 2025
Downgrades: Equal-Weight
Price Target: $20 → $16
Current: $12.94
Upside: +23.65%
Universal Health Services
Mar 10, 2025
Maintains: Overweight
Price Target: $230 → $225
Current: $178.19
Upside: +26.27%
Community Health Systems
Mar 10, 2025
Maintains: Underweight
Price Target: $2.5 → $2
Current: $2.84
Upside: -29.58%
Molina Healthcare
Mar 5, 2025
Upgrades: Overweight
Price Target: $295 → $372
Current: $319.63
Upside: +16.38%
Centene
Feb 14, 2025
Maintains: Overweight
Price Target: $76 → $72
Current: $59.78
Upside: +20.44%
CVS Health
Feb 13, 2025
Maintains: Overweight
Price Target: $68 → $73
Current: $67.40
Upside: +8.31%
The Cigna Group
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $333.01
Upside: +2.40%
Cardinal Health
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $135 → $136
Current: $151.99
Upside: -10.52%
Jan 28, 2025
Maintains: Overweight
Price Target: $694 → $660
Current: $404.81
Upside: +63.04%
Jan 28, 2025
Maintains: Overweight
Price Target: $483 → $478
Current: $416.30
Upside: +14.82%
Nov 27, 2024
Maintains: Overweight
Price Target: $17 → $21
Current: $20.41
Upside: +2.89%
Nov 25, 2024
Downgrades: Equal-Weight
Price Target: $205 → $150
Current: $149.03
Upside: +0.65%
Nov 25, 2024
Downgrades: Underweight
Price Target: $400 → $320
Current: $349.38
Upside: -8.41%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $256.69
Upside: +12.98%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.06
Upside: +112.46%
Feb 26, 2024
Maintains: Overweight
Price Target: $16 → $8
Current: $4.16
Upside: +92.31%